Answers are grounded in this paper and cite their sources.
Clinical update highlights personalized risk assessment and treatment options for osteoporosis management in affected populations, suggesting implications for practice.
The clinical update offers a concise overview of recently published, high-impact journal articles that may influence clinical practice, summarized for our readers. This edition highlights recent studies related to the diagnosis and management of osteoporosis. It reviews essential international guidelines on the clinical use of trabecular bone score (TBS) and a goal-oriented approach to treatment, alongside emerging data on the cardiovascular safety of romosozumab and evidence underscoring the underuse of zoledronate. In particular, it discusses the limited utilization of zoledronate in early postmenopausal women and its inpatient use in older adults after hip fractures.
No takes yet. Share an insight, caveat, or question.
Sung et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: